CVS Caremark (CVS) Continues Higher as FTC Drops Investigation
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $104.47 +0.13%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 3.3%
EPS Growth %: +1.1%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 3.3%
EPS Growth %: +1.1%
Join SI Premium – FREE
CVS Caremark (NYSE: CVS) is continuing higher Thursday, following a release that the FTC has dropped an investigation into the company's business practices.
Shares are now up 0.7 percent on the session, continuing to hit intraday highs.
Shares are now up 0.7 percent on the session, continuing to hit intraday highs.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CVS Health (CVS) PT Raised to $110 at Cantor Fitzgerald Post Checks
- CVS Health (CVS) PT Raised to $103 at HSBC
- CVS Health to hold second quarter 2026 earnings conference call
Create E-mail Alert Related Categories
Insiders' Blog, Litigation, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
